Article

Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation

Department of Pediatrics, Stanford School of Medicine, Stanford, California, USA.
Transplantation (Impact Factor: 3.78). 08/2005; 80(1):134-9. DOI: 10.1097/01.TP.0000164347.50559.A3
Source: PubMed

ABSTRACT Tissue regeneration and transplantation of solid organs involve complex processes that can only be studied in the context of the living organism, and methods of analyzing these processes in vivo are essential for development of effective transplantation and regeneration procedures. We utilized in vivo bioluminescence imaging (BLI) to noninvasively visualize engraftment, survival, and rejection of transplanted tissues from a transgenic donor mouse that constitutively expresses luciferase. Dynamic early events of hematopoietic reconstitution were accessible and engraftment from as few as 200 transplanted whole bone marrow (BM) cells resulted in bioluminescent foci in lethally irradiated, syngeneic recipients. The transplantation of autologous pancreatic Langerhans islets and of allogeneic heart revealed the tempo of transplant degeneration or immune rejection over time. This imaging approach is sensitive and reproducible, permits study of the dynamic range of the entire process of transplantation, and will greatly enhance studies across various disciplines involving transplantation.

0 Followers
 · 
186 Views
  • Source
    • "This early release of cytokines activates antigen presenting cells (APCs), resulting in the activation and proliferation of allo-reactive T cells (Ferrara et al., 2009). Bioluminescence imaging (BLI) is a sensitive tool that enables noninvasive in vivo monitoring of cells and provides important information on the biodistribution, proliferation, and persistence of cells (Cao et al., 2005; Panoskaltsis-Mortari et al., 2004; Weissleder and Pittet, 2008). For this reason, this technique has been used to track immune cells during GVHD, usually under MHC-mismatched conditions. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Graft-versus-host disease (GVHD) results from immunemediated attacks on recipient tissues by donor-originated cells through the recognition of incompatible antigens expressed on host cells. The pre-conditioning irradiation dose is a risk factor influencing GVHD severity. In this study, using newly generated luciferase transgenic mice on a B6 background (B6.Luc(Tg)) as bone marrow and splenocyte donors, we explored the effects of irradiation doses on donor cell dynamics in major histocompatibility complex (MHC)-matched allogeneic GVHD hosts via bioluminescence imaging (BLI). Results from BLI of GVHD hosts showed higher emission intensities of luminescence signals from hosts irradiated with 900 cGy as compared with those irradiated with 400 cGy. In particular, BLI signals from target organs, such as the spleen, liver, and lung, and several different lymph nodes fluctuated with similar time kinetics soon after transplantation, reflecting the synchronous proliferation of donor cells in the different organs in hosts irradiated with 900 cGy. The kinetic curves of the BLI signals were not synchronized between the target organs and the secondary organs in hosts irradiated with 400 cGy. These results demonstrate that pre-conditioning doses influence the kinetics and degree of proliferation in the target organs soon after transplantation. The results from this study are the first describing donor cell dynamics in MHC-matched allogeneic GVHD hosts and the influence of irradiation doses on proliferation dynamics, and will provide spatiotemporal information to help understand GVHD pathophysiology.
    Moleculer Cells 01/2012; 33(1):79-86. DOI:10.1007/s10059-012-2228-y · 2.24 Impact Factor
  • Source
    • "Mice used in the study were 6-to 8-week-old wild-type Swiss CD1 males, transgenic mice expressing ubiquitously GFP [30], or GFP and firefly luciferase [31] from colonies maintained in our institutional animal facility. All experimental procedures were performed according to the guidelines of the Italian National Institutes of Health and were approved by the Institutional Animal Care and Use Committee. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic ulcers represent a major health problem in diabetic patients resulting in pain and discomfort. Conventional therapy does not guarantee adequate wound repair. In diabetes, impaired healing is partly due to poor endothelial progenitor cells mobilisation and homing, with altered levels of the chemokine stromal-derived factor-1 (SDF-1) at the wound site. Adipose tissue-associated stromal cells (AT-SCs) can provide an accessible source of progenitor cells secreting proangiogenic factors and differentiating into endothelial-like cells. We demonstrated that topical administration of AT-SCs genetically modified ex vivo to overexpress SDF-1, promotes wound healing into diabetic mice. In particular, by in vivo bioluminescent imaging analysis, we monitored biodistribution and survival after transplantation of luciferase-expressing cells. In conclusion, this study indicates the therapeutic potential of AT-SCs administration in wound healing, through cell differentiation, enhanced cellular recruitment at the wound site, and paracrine effects associated with local growth-factors production.
    12/2010; 2011(1687-966X):304562. DOI:10.4061/2011/304562
  • Source
    • "In addition, while housekeeping promoters are widely used in cell culture to achieve uniform and high-level expression, they have proved problematic in transgenic animals with highly variable patterns of expression (Kisseberth et al. 1999). One luciferase transgenic line has been made utilizing a CMV-chicken β-actin promoter, but was noted to express the reporter only in a selected group of tissues that did not include brain (Cao et al. 2005). We chose the GAPDH promoter for control of the Renilla luciferase based on its frequent use in normalizing expression data, and recent studies indicate its utility for studies of chronic neurodegenerative disease in the mouse (Calvo et al. 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glial fibrillary acidic protein (GFAP) is the major intermediate filament protein of astrocytes, and its expression changes dramatically during development and following injury. To facilitate study of the regulation of GFAP expression, we have generated dual transgenic mice expressing both firefly luciferase under the control of a 2.2 kb human GFAP promoter and Renilla luciferase under the control of a 0.5 kb human Glyceraldehyde 3 phosphate dehydrogenase (GAPDH) promoter for normalization of the GFAP signal. The GFAP-fLuc was highly expressed in brain compared to other tissues, and was limited to astrocytes, whereas the GAPDH-RLuc was more widely expressed. Normalization of the GFAP signal to the GAPDH signal reduced the inter-individual variability compared to using the GFAP signal alone. The GFAP/GAPDH ratio correctly reflected the up-regulation of GFAP that occurs following retinal degeneration in FVB/N mice because of the rd mutation. Following kainic acid-induced seizures, changes in the GFAP/GAPDH ratio precede those in total GFAP protein. In knock-in mice expressing the R236H Alexander disease mutant, GFAP promoter activity is only transiently elevated and may not entirely account for the accumulation of GFAP protein that takes place.
    Journal of Neurochemistry 06/2009; 110(1):343-51. DOI:10.1111/j.1471-4159.2009.06146.x · 4.24 Impact Factor
Show more